Company Mondopharm S.r.l. with Fiscal Code 6557893
recorded a turnover of 2024 of
216.172,
with a net profit of
33.892
and having an average number of employees of
- .
The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Mondopharm S.r.l.
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
171.300
163.246
167.827
173.656
179.310
179.243
162.934
150.823
170.638
216.172
Total Income - EUR
171.300
163.246
167.827
173.666
179.315
179.244
162.936
150.826
170.641
216.182
Total Expenses - EUR
149.445
143.571
143.860
150.058
154.141
156.867
145.002
136.836
156.920
175.804
Gross Profit/Loss - EUR
21.855
19.674
23.967
23.608
25.173
22.377
17.933
13.990
13.721
40.378
Net Profit/Loss - EUR
18.287
16.480
22.086
21.871
23.380
20.585
16.304
12.482
12.015
33.892
Employees
4
4
4
4
4
4
4
4
4
0
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 27.4%, from 170.638 euro in the year 2023, to 216.172 euro in 2024.
The Net Profit increased by 21.945 euro, from 12.015 euro in 2023, to 33.892 in the last year.
Check the financial reports for the company - Mondopharm S.r.l.
Financial Rating - MONDOPHARM S.R.L.
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Mondopharm S.r.l.
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Mondopharm S.r.l.
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Mondopharm S.r.l.
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
59.185 euro in 2024 which includes Inventories of
24.018 euro, Receivables of
17.457 euro and cash availability of
17.710 euro.
The company's Equity was valued at
1.460 euro, while total Liabilities amounted to
57.725 euro.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Mondopharm S.r.l.